Abstract: Rapid diagnostics remain essential for outbreak response, yet most platforms are inherently limited by their reliance on prior knowledge of specific pathogens. This constraint is especially critical for flaviviruses, a rapidly evolving group with frequent zoonotic spillover and high potential for the emergence of unknown or poorly characterized strains. This work addresses that gap by developing multiplexed lateral flow assays (LFAs) designed not just to detect known viruses, but to identify and flag the unknown through pattern-based sensing. By leveraging antibody cross-reactivity, nanoparticle color encoding, and multivariate analysis, these assays generate distinct signal fingerprints that move beyond binary detection toward identifying unfamiliar viral signatures.
Using flaviviruses as a primary model system, this thesis establishes a sensor-array paradigm in which cross-reactive antibodies and multicolor nanoparticle labels produce unique colorimetric patterns across the Orthoflavivirus genus. Combined with unsupervised learning approaches such as principal component analysis and hierarchical clustering, this platform enables both classification of known viruses and recognition of anomalous, previously unseen patterns indicative of unknown threats. Together, this work presents a generalizable diagnostic framework capable of adapting to viral evolution, offering a path toward rapid, field-deployable detection of emerging and re-emerging flaviviruses without requiring target-specific reagents.
Launched to the International Space Station on March 14th, 2023, Mission SpaceX CRS-27.
As part of the AmpliRx Space Pharmacy mission, 60 inaugural experiments were launched to the International Space Station to explore distributed manufacturing of biomaterials and life-saving medications. Leveraging the unique constraints of the space environment, our goal was to reimagine sustainable, low-carbon pathways for drug manufacturing that could improve global access to medicines.
My contributions included designing and conducting experiments in chemical synthesis and verification, optimizing microfluidic systems, streamlining data analysis workflows, and contributing to engineering design solutions.

Boston, MA
“A novel immunoassay technique using principal component analysis for enhanced detection of emerging viral variants.”

Denver, CO
“A novel immunoassay technique using principal component analysis for enhanced detection of emerging viral variants.”

Boston, MA
“Ampli Powered Papermechanical Synthesis in Space: Results from a new approach biopharmaceutical synthesis in LEO / In Space Mfg”
*assisted in Q&A

Brandeis University, MA
“Paper Powered Pharmaceutical Manufacturing” sound bite.
“Whatever you do, work at it with all your heart, as working for the Lord, not for human masters, since you know that you will receive an inheritance from the Lord as a reward. It is the Lord Christ you are serving” -Colossians 3:23–24